Other languages Helix BioPharma Corp.

Equities

HBP

CA4229101098

Market Closed - Toronto S.E. Other stock markets 15:51:13 2024-05-14 EDT			5-day change	1st Jan Change
0.21 ^CAD	-8.70%		-4.55%	0.00%

04-08	Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding	CI
03-28	Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Helix BioPharma Corp. Appoints Praveen Varshney as Corporate Secretary	02-13
Helix BioPharma Corp. Reports Earnings Results for the First Quarter Ended October 31, 2023	12-14
Helix BioPharma Corp. Reports Earnings Results for the Full Year Ended July 31, 2023	23-10-27
Helix BioPharma Corp. to Present New Preclinical Data on L-DOS47 in Combination with PD1 Checkpoint Inhibitor at the 2023 AACR- NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	23-10-10
Helix Biopharma Corp. Announces Board Changes	23-08-22
Helix BioPharma Corp. Announces Executive Changes	23-08-22
Helix BioPharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-14
Helix BioPharma Corp. Reports Earnings Results for the First Quarter Ended October 31, 2022	22-12-14
Helix BioPharma Corp. Announces Board Changes	22-12-08
Helix BioPharma Corp. Announces CEO Changes	22-12-08
Helix BioPharma Corp. Reports Earnings Results for the Full Year Ended July 31, 2022	22-10-31
Helix BioPharma Corp. Auditor Raises 'Going Concern' Doubt	22-10-30
Helix BioPharma Corp. Appoints Frank Gary Renshaw as Chief Medical Officer	22-10-03
Helix BioPharma Corp. Appoints Gabrielle M Siegers as Head of Research Development Based Out of its Lab in Edmonton	22-09-01
Helix BioPharma Corp. Enters into Two-Year Scientific Collaboration Agreement with University Hospital Tuebingen	22-08-08
Helix BioPharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	22-06-14
Helix BioPharma Corp. Appoints Namrata Malhotra as Corporate Secretary	22-05-18
Helix Biopharma Corp. Appoints Artur Gabor as Chief Executive Officer	22-04-18
Helix Biopharma Corp. Announces Board Changes	22-04-18
Helix Biopharma Corp. Announces Resignation of Krzysztof Saczek from the Board of Directors	22-04-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Helix BioPharma Corp.

Equities

HBP

CA4229101098

Other languages

Filters